Brokerages Set Integral Ad Science Holding Corp. (NASDAQ:IAS) PT at $16.20

Integral Ad Science Holding Corp. (NASDAQ:IAS) has been given an average recommendation of “Moderate Buy” by the eleven research firms that are currently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $15.70.

IAS has been the topic of a number of research analyst reports. Oppenheimer dropped their price target on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday. Piper Sandler dropped their target price on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research report on Wednesday. Morgan Stanley lifted their target price on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 23rd. Craig Hallum dropped their target price on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, Raymond James lifted their target price on Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd.

Integral Ad Science Trading Down 6.1 %

NASDAQ IAS opened at $10.11 on Wednesday. The firm has a market cap of $1.64 billion, a P/E ratio of 50.55, a P/E/G ratio of 1.46 and a beta of 1.52. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.76. The stock’s 50-day moving average is $11.09 and its 200-day moving average is $10.47. Integral Ad Science has a one year low of $7.98 and a one year high of $17.53.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. The company had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Integral Ad Science’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.09) earnings per share. Sell-side analysts anticipate that Integral Ad Science will post 0.25 earnings per share for the current fiscal year.

Insider Buying and Selling at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 10,481 shares of Integral Ad Science stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at approximately $2,423,457.99. This trade represents a 4.19 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Tania Secor sold 5,240 shares of Integral Ad Science stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the sale, the chief financial officer now directly owns 248,223 shares of the company’s stock, valued at approximately $2,509,534.53. The trade was a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,006 shares of company stock worth $240,296 over the last ninety days. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Integral Ad Science

Hedge funds have recently added to or reduced their stakes in the company. Point72 DIFC Ltd acquired a new position in Integral Ad Science in the 3rd quarter valued at $41,000. nVerses Capital LLC acquired a new position in Integral Ad Science in the 3rd quarter valued at $45,000. Ameritas Investment Partners Inc. raised its holdings in Integral Ad Science by 40.1% in the 1st quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after acquiring an additional 1,924 shares in the last quarter. Quantbot Technologies LP acquired a new position in Integral Ad Science in the 3rd quarter valued at $106,000. Finally, XTX Topco Ltd acquired a new position in Integral Ad Science in the 2nd quarter valued at $113,000. 95.78% of the stock is owned by institutional investors and hedge funds.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.